U.S. Aerospace & Defense Stock News

Ituran Location and Control (NasdaqGS:ITRN) has filed a universal shelf registration, allowing the company to issue a range of securities in the future. The filing enables potential offerings of ordinary shares, debt securities, warrants, and rights, depending on future funding needs and market conditions. Ituran Location and Control operates in vehicle tracking and telematics, providing location based services and control systems. The new shelf registration adds an extra funding tool...

Earnings and Clinical Data Put Roivant in Focus Roivant Sciences (ROIV) has moved into the spotlight after reporting Phase 2b results for IMVT-1402 in difficult-to-treat rheumatoid arthritis, alongside recent fourth quarter earnings and a new shelf registration filing. See our latest analysis for Roivant Sciences. At a share price of US$29.88, Roivant has seen a 36.25% year to date share price return and a very large 1 year total shareholder return, suggesting momentum has built around the...

Kimberly-Clark (NasdaqGS:KMB) announced plans to acquire consumer health company Kenvue, marking a major expansion beyond its core tissue and personal care products. The deal is framed as a way to build a broader consumer health portfolio and create operational synergies across brands and distribution channels. Institutional investors such as Diamond Hill Capital have added NasdaqGS:KMB following the announcement, highlighting the perceived importance of this transaction. Kimberly-Clark is...

In the past few days, law firm Levi & Korsinsky began investigating ZoomInfo Technologies Inc. for potential federal securities law violations after the company sharply reduced its 2026 revenue and operating income guidance following earlier upbeat forecasts. The sudden guidance cut, coming so soon after optimistic full-year expectations, has raised fresh questions for investors about management communication and forecasting reliability. We’ll now explore how this new legal investigation...

Rezolve AI (RZLV) is back in focus after Enhanced Group Inc. selected the company to power Live Enhanced, a new direct to consumer digital telehealth platform built around AI driven medical concierge services. See our latest analysis for Rezolve AI. Rezolve AI's latest partnership news lands after a mixed price pattern, with a 1 day share price return of 9.02%, a 90 day share price return of 19.31% and a 3 year total shareholder return that is still down 72.88%. Recent momentum appears to be...

Earlier this week, Masco reported that it delivered solid sales growth, expanded margins and higher earnings in its latest quarterly results despite ongoing macroeconomic uncertainty, supported by its established brands, pricing power and steady professional renovation demand. At the same time, commentary around flat organic revenue over the past two years and softer projected sales growth highlighted rising competitive pressures and questions about how Masco will sustain expansion without...

Uranium Energy (NYSEAM:UEC) has appointed Bradley Williams as Vice President of Government Affairs. Williams brings executive level experience in nuclear energy policy and federal government relations. The role is focused on strengthening Uranium Energy's presence in U.S. federal policy and the domestic nuclear fuel cycle. Uranium Energy, trading around $13.55, has drawn attention with a very large 3 year return and a 1 year return of 125.5%. The stock is up 3.4% over the past week,...

Recent trading action in Caesars Entertainment (CZR) Caesars Entertainment (CZR) recently drew fresh attention after its stock moved to around $29.08, with short term returns over the month and past 3 months prompting investors to reassess the casino and hospitality group. See our latest analysis for Caesars Entertainment. That recent move to US$29.08 comes after a 6.48% 1 month share price return and a 16.09% 3 month share price return, while the 1 year total shareholder return of 6.64%...

Why Carter's Stock Is On Investors' Radar Carter's (CRI) stock has drawn attention after recent share price moves, with the company showing a 1.9% return over the past day and nearly 6.8% over the past week. See our latest analysis for Carter's. That short burst of interest sits on top of a longer stretch where the share price has gained 20.8% year to date and 19.6% over three months, yet the 3 year total shareholder return is down 25.7% and the 5 year total shareholder return is down 52.5%...

Applied Digital (APLD) moved into focus after announcing a 15-year take-or-pay lease with a high investment-grade U.S. hyperscaler for its Polaris Forge 3 AI campus, adding substantial contracted revenue visibility. See our latest analysis for Applied Digital. That long term lease announcement comes on the back of strong momentum, with a 30 day share price return of 54.62% and an 82.07% 90 day share price return. The 1 year total shareholder return is very large, suggesting investors see...

GitLab (GTLB) is back in focus after releasing GitLab 19.0 and expanding its Carahsoft partnership. These developments reshape how customers access its DevSecOps platform across security, AI agents, and commercial channels. See our latest analysis for GitLab. GitLab’s recent product and channel announcements arrive after a mixed run in the stock, with a 24.47% 1 month share price return and 9.02% 7 day share price return contrasting with a year to date share price decline of 22.80% and a 1...

The Clorox Company recently disclosed that Chair and CEO Linda Rendle has asked the board to begin a comprehensive CEO search as she plans to step down for health reasons, while remaining in her role through the transition and then serving as an advisor. This planned leadership change, guided by an independent board search committee and external executive search firm, introduces a fresh governance milestone that could influence how Clorox executes its longer-term operational and portfolio...

Investors may be wondering if Amprius Technologies stock is still priced fairly after its recent run, or if expectations have already gone too far into the future. At a last close of US$20.85, the stock has delivered 36.3% over the past week, 5.9% over the past month and 138.6% year to date, with a very large 1-year return of around 7x. Recent headlines have focused on Amprius Technologies as a high growth battery technology stock, which has drawn more attention from both institutional and...

On May 28, 2026, Piedmont Realty Trust and its operating partnership amended their January 2024 term loan, increasing the facility to US$400 million, extending maturity to May 28, 2031, and tying the interest margin to credit ratings and leverage, with the current rate set at SOFR plus 1.15%. The ability to prepay this enlarged, long-dated term loan without penalty and the rating-linked pricing grid highlight active balance sheet management aimed at preserving flexibility and aligning...

ComEd, an Exelon (NasdaqGS:EXC) subsidiary, has surpassed US$10b in Renewable Energy Credits under contract. The milestone is recorded as of the end of 2025 and reflects activity in Illinois. The contracts relate to renewable energy growth across the state, including support for clean power projects. For you as an investor, this milestone highlights how a regulated utility within Exelon is tied into Illinois’ push for cleaner power. Renewable Energy Credits are a policy tool that helps fund...

Coupang (NYSE:CPNG) is dealing with an extensive 2025 data breach affecting over 33 million customer accounts. The company has outlined a $1.2b customer compensation program in response to the incident. Management is stressing recovery efforts, cyber security upgrades, and a $2b share buyback while addressing the fallout. Coupang is under close scrutiny after the breach, with the response shaping how customers and investors view the business. The stock trades around $16.2, with shares down...

United Airlines Holdings stock snapshot Without a single defining news event driving recent attention, United Airlines Holdings (UAL) is drawing interest as investors reassess its returns, profitability, and valuation following a strong year and solid multi year performance. See our latest analysis for United Airlines Holdings. United Airlines Holdings has seen strong short term momentum, with a 30 day share price return of 27.26% and a 1 year total shareholder return of 46.44% reinforcing a...

Recent share performance and business snapshot ADMA Biologics (ADMA) has drawn investor attention after a sharp pullback, with the stock down about 27% over the past month and roughly 49% over the past 3 months from a last close of US$7.93. Against this weaker recent share performance, the company reports annual revenue of US$509.864 million and net income of US$165.354 million, supported largely by its ADMA BioManufacturing segment and a smaller contribution from Plasma Collection...

On May 19, 2026, First Merchants Corporation announced director Gary Lehman’s retirement from the board and declared a US$0.3700 quarterly dividend payable on June 19, 2026. The simultaneous addition of former KPMG partner Paul Fultz to the board and its Audit Committee highlights a reinforced focus on financial reporting and governance oversight. We’ll now examine how the appointment of experienced audit partner Paul Fultz could influence First Merchants’ existing investment narrative and...

Wondering if AutoZone at around US$3,007 a share still offers value, or if the best entry point might have passed? This article breaks down what the current price really implies. The stock has had a rough patch recently, with the share price falling 12.5% over the past week, 15.6% over the past month, and sitting down 9.0% year to date, even though the 3 year and 5 year returns are 26.7% and 116.0% respectively. Recent headlines have focused on how AutoZone fits into the broader shift in...

Immunome, Inc. recently drew investor attention as Barclays initiated coverage with an Overweight rating and the company prepared a presentation at the Goldman Sachs 47th Annual Global Healthcare Conference, with the webcast made available via its Investor Relations site. This combination of positive analyst commentary and visibility at a high-profile healthcare conference underscores Immunome’s positioning within the increasingly active antibody-drug conjugate space. We’ll now consider how...

Vaxcyte stock snapshot after recent performance shifts Vaxcyte (PCVX) has drawn fresh attention after a mixed stretch for the stock, with a small gain over the past day but declines over the past month and past 3 months shaping recent sentiment. See our latest analysis for Vaxcyte. Recent moves leave Vaxcyte with a 7 day share price return of 7.7% but a 30 day share price return down 13.1%, while the 1 year total shareholder return of 55.7% points to momentum that has been building over a...

Wondering if AeroVironment at around US$214 per share is still a good deal, or if the easy gains are already behind it? This article focuses squarely on what the current valuation might be telling you. The stock has moved sharply in the short term, with a 23.1% gain over the last 7 days and 16.8% over the last 30 days, while the return over the last year sits at 20.4%. The 3 year and 5 year returns are 116.9% and 92.6% respectively, and year to date the stock is down 16.3%. These swings have...

Earlier this week, Lithia & Driveway (NYSE: LAD) said it had bought back 1,450,000 shares since January 1, 2026 for US$396 million, bringing total repurchases under its long-running program to 12,746,867 shares for US$2.93 billion, or just under half of its shares, and simultaneously lifted its overall authorization to US$3.60 billion. The additional US$500 million authorization, leaving US$726 million still available, highlights management’s willingness to keep deploying substantial capital...